EMD p.Pro183Ser
c.547C>T · rs104894806 · VCV1038252
Computational evidence
| Protein change | ||
| AlphaMissense | 0.1339 | likely benign |
|---|---|---|
| REVEL | 0.303 | indeterminate |
| SaProt | LLR -6.96 | tolerated |
| ⇒ AlphaMissense and SaProt both call this tolerated; REVEL makes no call. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 5.3 | GERP 1.6, phastCons 1 |
| Regional constraint | o/e 1.05 | unconstrained · MANE · 1,709 bp · p 0.47 · regional, not allelic |
| Overall | ||
| CADD | 16.76 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- EMD
- Protein
- p.Pro183Ser
- Coding
- c.547C>T
- MANE Select
- NM_000117
- dbSNP
- rs104894806
- Type
- single nucleotide variant
- Location
- chrX:154380979 (GRCh38)
- Structure
- AlphaFold pLDDT 61.26 · 6 PDB
- Residue 183
- a UniProt-annotated variant site (in edmd1; likely pathogenic; no loss of binding to f-actin; enhanced rate of actin polymerization); a UniProt-annotated variant site (in edmd1; likely pathogenic); the 'interaction with f-actin' region; the 'interaction with ctnnb1' region
Similar variants
- EMD p.Pro183His Pathogenic ★ ⚠ same residue
- EMD p.Pro183= Conflicting classifications of pathogenicity ★ same residue
- EMD p.Pro183Arg Uncertain significance ★ ⚠ same residue
- EMD p.Pro183Leu Conflicting classifications of pathogenicity ★ ⚠ same residue
- EMD p.Pro183Thr Pathogenic ⚠ same residue
- EMD c.187+1G>A Pathogenic ★★ same condition
- EMD c.187+1G>T Pathogenic/Likely pathogenic ★★ same condition
- EMD c.265+1G>A Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/emd-p-pro183ser (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown